Takara Bio Inc. reported unaudited consolidated earnings results for the first quarter ended June 30, 2021. For the quarter, the company reported net sales of ¥15,272 million against ¥6,938 million a year ago. Operating profit was ¥8,504 million against ¥693 million a year ago. Net income attributable to owners of parent was ¥6,025 million against ¥404 million a year ago. Net income per share was ¥50.4 against ¥3.36 a year ago.